Please wait...

Learn

Finding accredited CPD

Medicinal Cannabis - Treatment resistant pain, neuropathic pain, cluster headaches and migraines

Description

This course is designed to empower healthcare professionals with the skills and knowledge required to assess, prescribe, and manage medicinal cannabis for patients experiencing chronic or intractable pain and headaches. It highlights evidence-based practices, therapeutic mechanisms, and real-world clinical applications. No prerequisites are required, although a basic understanding of the endocannabinoid system, THC and CBD, and administration routes is recommended.

Unit 1: Headaches – Clinical Overview & Classification
This unit introduces the clinical landscape of treatment-resistant headaches, including:

  • Cluster Headaches: Rare but extremely painful, with a prevalence of chronic cases requiring long-term management. Epidemiology, familial risk, and treatment challenges are explored
  • Migraines: Focus on episodic and chronic subtypes, with detailed diagnostic criteria. The role of cortical spreading depression, aura phenomena, and risk factors such as stroke and psychiatric comorbidities are addressed
  • Medication Overuse Headache (MOH): Differentiating MOH from chronic migraines, causes, and withdrawal strategies
  • Diagnostic Frameworks: Primary vs secondary headaches, red flags, and neuroimaging indications. The unit sets the clinical foundation necessary to explore cannabinoid-based interventions in subsequent units.

Unit 2: The Role of Cannabinoids in Pain and Headache Management
This unit examines how cannabinoids function in the body and their potential therapeutic effects:

  • Mechanisms of Action: Interaction with CB1/CB2 receptors, TRPV1 channels, serotonergic pathways, and the endocannabinoid system
  • Evidence Base: Reviews major studies, including Cochrane and Canadian guidelines, assessing the efficacy of cannabis in neuropathic and headache disorders
  • Cannabinoid Pharmacology: How CBD and THC alleviate pain, impact neurotransmission, and support neuroprotection
  • Headache-Specific Data: Focus on cannabinoid impact on migraines and cluster headaches, including limitations in current evidence and anecdotal reports
  • The Entourage Effect: Synergistic benefits of full-spectrum cannabis over isolates. The unit contextualizes cannabis as a third-line therapy, emphasizing its adjunctive potential in complex pain syndromes.

Unit 3: Practical Considerations for Prescribing Medicinal Cannabis
This final unit provides practical, clinician-focused guidance on integrating cannabis into patient care:

  • Patient Assessment: Clinical history, contraindications (e.g. psychosis, pregnancy), and shared decision-making
  • Formulations & Dosing: Oral, sublingual, and inhaled options. “Start low, go slow” titration principles, balancing THC and CBD, and personalised treatment strategies
  • Monitoring & Adjustments: Setting treatment goals, regular reviews, dose optimisation, and planning an exit strategy
  • Safety & Compliance: Addressing legal considerations (e.g. driving with THC), medication interactions, and consent procedures
  • TGA Guidance & Access Pathways: Special Access Scheme (SAS B), Authorised Prescriber route, and medical-grade vaporisers. Case examples and graphics aid in applying these concepts practically to real-world scenarios.

This course equips general practitioners with the clinical confidence and evidence-based framework to prescribe medicinal cannabis where appropriate. It fosters safe, ethical, and personalised care for patients who have not responded to conventional treatments for chronic pain and headache conditions.


Learning Outcomes

  1. Plan the management of treatment resistant pain, neuropathic pain with medicinal cannabis
  2. Plan the management of treatment of cluster headaches and migraines with medicinal cannabis.

Details

Cost: $195

Suitable for: All degree qualified medical practitioners.

Study mode: 100% online

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard. 

CPD Activity Details
Provider
Domain
Educational Activities
Type
General Learning
Activity
Course / module
CPD Hours
10h : 30m
Topic
General Practice and Primary Care
Audience
Medical practitioners
Applicable CAPE Aspects
_
Effective Year

You have to log in to see the content of this module.


Provided by


Accredited by

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)